Our mission is to use canine scent detection to develop a non-invasive way of screening for cancer and other life threatening diseases. We will deliver cost effective, scalable testing for the early detection of cancer, arming patients with the best opportunity for eradicating the disease.
Role: Business Operations
Mr. Moore has over 20 years of business and corporate development experience with technology start-ups. Most recently he served as COO for peerVue, Inc.
Role: Business Development
Mr. Lawton has over 20 years of healthcare experience. Before joining BioScent, He was co-founder and CEO of peerVue, Inc. peerVue was acquired by McKesson, the largest healthcare company in the world in 2012.